Location: Home
  • search
  • go
  • Relate News
  • 7/21/2017Latest Data Set from SMEI: China's Pharma Market Growth Down to 7.8% i...
  • 7/14/2017Chinese Retail Drug Sales Growth Flat in the First Half of 2017
  • 7/14/2017CFDA Issues 2016 Annual Report for Biological Product Batch Release
  • 7/12/2017Branded Generics in the Emerging Markets
  • 7/12/2017Performance of Most Domestically-listed Chinese Pharma Companies Conti...
  • 7/6/2017SMEI Reports on Chinese Pharma Performance in H1/2017 and Maintain Ear...
  • 7/5/2017Why Big Pharma Is Targeting China's Deadliest Diseases
  • 7/3/2017Top 20 Domestically-listed Pharma Companies by Capitalization in 2017
  • 7/3/2017SMEI Releases Ranking of Top 100 Chinese Pharmaceutical Companies in 2...
  • 6/29/2017NDRC and MOFCOM Jointly Issue the 2017 Edition of Foreign Investment G...
  • 6/8/2017QuintilesIMS: Review of Chinese Pharmaceutical Market in 2016
  • 6/8/2017Snapshot of Seven Listed Chinese Regional Drug Distributors 2016
  • 6/7/2017Chinese Pharma Returns to Double Digit Growth in First Four Months of ...
  • 5/30/2017NYT: China's Ill, and Wealthy, Look Abroad for Medical Treatment
  • 5/16/2017Big Pharma Hopes Rule Change Will Ease China Sales Pain
  • 5/12/2017CFDA Solicits Comments on New Policy on Protecting Innovator Rights
  • 5/12/2017CFDA Solicits Comments on New Policy on Reforming Clinical Trial Regul...
  • 5/10/2017Review of Chinese Pharma Marketing and Digital Communications in 2016
  • 5/9/2017Snapshot of Top 17 A-Share Listed Chinese Pharma Firms by Net Profits ...
  • 5/8/2017Performance of Listed Domestic Pharma Companies Improves in Q1/2017
  • 5/2/2017SMEI Release Data Set on Chinese Drug Terminal Market 2010-2016
  • 4/26/2017China's New Foreign Drug Proposal: Pharmas Excited, Analysts Cautious
  • 4/26/2017MIIT Reports Chinese Pharmaceutical Industry Performance in 2016
  • 4/26/2017Performance Snapshot of Leading Regional Pharmaceutical Distributors i...
  • 4/20/2017Domestically-listed Pharma Companies Report Impressive 2016 Performanc...
  • 4/20/2017Generic Consistency Evaluation in China: The Coming Paradigm Shift In ...
  • 4/19/2017R&D Spending of Top Domestically-Listed Pharmaceutical Companies i...
  • 4/18/2017Novartis CEO Anticipates Accelerated Chinese Pharma Growth
  • 4/5/2017Listed Chinese Pharma Cos Maintains Growth in 2016
  • 4/3/2017Novartis CEO: Why China Is a Healthy Investment
  • Page:25/38 Total number of articles:1139: [First][<<] [23] [24] [25] [26] [27] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group